TNDM:NASDAQ
Tandem Diabetes Care Inc
16,50 US$
0,00%
(0,00) 1D
16,55 US$
arrow_upward
+0,30% (+0,050)todayPre-market
Closed: 2 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Mkt. cap
1,15 მლრდ.
Avg. vol.
1,93 მლნ.
Volume
11,68 ათ.
52-wk high
29,65 US$
52-wk low
12,26 US$
EPS
-0,93 US$
Beta
1,66
Shares outstanding
69,58 მლნ.
No. of employees
2 ათ.
Mkt. cap
1,15 მლრდ.
Avg. vol.
1,93 მლნ.
Volume
11,68 ათ.
52-wk high
29,65 US$
52-wk low
12,26 US$
EPS
-0,93 US$
Beta
1,66
Shares outstanding
69,58 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Stock Traders Daily
·
1 დღის წინ
(TNDM) as a Liquidity Pulse for Institutional Tactics
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOჯონ შერიდან
Employees2,5 ათ.
Foundedიან 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com